Genpact Limited (NYSE:G) Shares Acquired by Renaissance Technologies LLC

Renaissance Technologies LLC increased its holdings in Genpact Limited (NYSE:G - Free Report) by 26.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 155,500 shares of the business services provider's stock after buying an additional 32,651 shares during the period. Renaissance Technologies LLC owned about 0.09% of Genpact worth $6,679,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. SRH Advisors LLC acquired a new position in shares of Genpact during the fourth quarter worth $26,000. Atlas Capital Advisors Inc. raised its stake in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after buying an additional 216 shares during the last quarter. Manchester Capital Management LLC acquired a new stake in Genpact in the fourth quarter worth about $38,000. Smartleaf Asset Management LLC grew its stake in shares of Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after acquiring an additional 783 shares during the last quarter. Finally, UMB Bank n.a. increased its holdings in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after acquiring an additional 433 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Price Performance

NYSE G traded up $0.41 on Thursday, hitting $47.96. The company had a trading volume of 199,143 shares, compared to its average volume of 1,343,225. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The company has a market capitalization of $8.42 billion, a PE ratio of 16.87, a PEG ratio of 1.84 and a beta of 1.06. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The company's fifty day moving average price is $50.04 and its 200-day moving average price is $46.20.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.42%. The ex-dividend date of this dividend was Tuesday, March 11th. This is a boost from Genpact's previous quarterly dividend of $0.15. Genpact's payout ratio is 23.94%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Needham & Company LLC boosted their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Mizuho upped their target price on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and boosted their price target for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and lifted their target price for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Five analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $50.38.

Insider Transactions at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.80% of the company's stock.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.